SocialPicks Monitor new  |    Stock Idea Community
Sign Up   |   Log in   |   Feedback
Logo

Search and browse top stock market blogs & videos   (e.g. "AAPL" or "iPhone")
  

GlaxoSmithKline plc (GSK)

   Add Add to Watchlist
You are not subscribed to the GSK feed yet.    Add GSK to Watchlist »
researchrecap.com - Dec 12, 2008   about  NVS, MRK, JNJ and 3 more
Big pharmaceutical companies on both sides of the Atlantic are supposed to be recession-proof, but it may be different in this global recession, depending on who you ask. Fitch Ratings notes that global pharmaceutical sales grew by an average 6.5 percent in the third quarter, excluding merger-relate...
add a comment   |   Email

247wallst.com - Nov 17, 2008   about  GSK
On Friday, ChemoCentryx Inc. filed to withdraw its pending registration for an IPO of up to $57.5 million. The market conditions of today are cited as the... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]
add a comment   |   Email

fool.com - Oct 24, 2008   about  GSK, EXEL
Glaxo says goodbye to Exelixis.
add a comment   |   Email

thestreet.com - Oct 23, 2008   about  CSCO, GSK, DD and 2 more
Cisco, GlaxoSmithKline, DuPont, Mattel and Polo Ralph Lauren are downgraded.
add a comment   |   Email

investors.com - Oct 14, 2008   about  PFE, BMY, GSK and 2 more
Sometimes you have to take the long view.
add a comment   |   Email

fool.com - Sep 30, 2008   about  GSK, AZN, NVS
The credit rating agency frowns on European pharmaceuticals.
add a comment   |   Email

zacks.com - Sep 30, 2008   about  GSK
We are worried about the recent negative news surrounding the company’s second-largest-selling drug, Avandia. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This p...
add a comment   |   Email

fool.com - Sep 23, 2008   about  TEVA, GSK, BVF and 2 more
The FDA is still investigating Teva's generic Wellbutrin XL.
add a comment   |   Email

fool.com - Sep 11, 2008   about  GSK
The pharmaceutical's deal for a drug developer is back-end loaded.
add a comment   |   Email

enlightened-american.com - Aug 20, 2008   about  AMGN, GSK, JOE and 7 more
In their 13F-HR filing for Q2 2008, Bruce Berkowitz and his cohorts at the Fairholme Fund continue their shift from energy into healthcare: Fairholme opened huge (relative) positions in Pfizer (PFE), Forest Labs (FRX) and UnitedHealth Group (UNH). The UNH position echos Seth Klarman’s endorsement....
add a comment   |   Email